26 March 2008 Sosei Announces Temporary Halt to AD 923 CBP Phase III Studies in Europe 20 February 2008 Sosei Announces Initiation of Phase III Trial for NorLevo® 12 February 2008 Summary of Consolidated Financial Results for the 3Q ended 31st December 2007 (abridged English version ) Sosei Announces Start of AD 923 Phase III Studies in Europe 18 January 2008 Update of NVA237 and QVA149 Development Programme 13 December 2007 Sosei and Vectura Announce Start of Phase II Efficacy Study of QVA149   For past news and financial report, please go to News and Financial Data.